A5101617514- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiac Arrhythmias and Treatments
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Coronary Interventions and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Mechanical Circulatory Support Devices
- Congenital Heart Disease Studies
- Cardiac and Coronary Surgery Techniques
- Orthopaedic implants and arthroplasty
- Cerebrovascular and Carotid Artery Diseases
- Nanoparticle-Based Drug Delivery
- Biosimilars and Bioanalytical Methods
- Innovation Policy and R&D
- Cardiovascular Issues in Pregnancy
- Hip disorders and treatments
- Cardiac Health and Mental Health
- Clinical practice guidelines implementation
- Cancer Treatment and Pharmacology
- Digital Imaging in Medicine
- Meta-analysis and systematic reviews
- Takotsubo Cardiomyopathy and Associated Phenomena
Los Robles Hospital & Medical Center
2022-2025
Regional Medical Center
2022-2024
Bakersfield Heart Hospital
2023
Boston Scientific (United States)
2022
Cedars-Sinai Medical Center
2019
Abstract Background and Aims This trial sought to assess the safety efficacy of ShortCut, first dedicated leaflet modification device, prior transcatheter aortic valve implantation (TAVI) in patients at risk for coronary artery obstruction. Methods pivotal prospective study enrolled with failed bioprosthetic valves scheduled undergo TAVI were The primary endpoint was procedure-related mortality or stroke discharge 7 days, per-patient splitting success. Independent angiographic,...
Cardiac computed tomography (CT) is increasingly utilized during follow-up after left atrial appendage closure (LAAC). Hypoattenuated thickening (HAT) a common finding and might represent either benign device healing or device-related thrombosis (DRT). The appearance characteristics of HAT associated with the Watchman FLX have not been previously described. Therefore, we sought to investigate cardiac CT findings implantation focus on DRT. Retrospective single-centre, observational study...
BACKGROUND: The clinical significance of elevated baseline natriuretic peptide level and prior heart failure hospitalization (HFH) within the year in mitral transcatheter edge-to-edge repair outcomes is unclear. This analysis examined impact BNP (B-type peptide) or N-terminal prohormone NT-proBNP (N-terminal pro-B-type HFH on patients with severe secondary regurgitation. METHODS: COAPT trial (Cardiovascular Outcomes Assessment MitraClip Percutaneous Therapy for Heart Failure Patients With...
Mitral annular calcification (MAC) negatively influences outcomes in surgical mitral valve (MV) repair for regurgitation (MR). However, there are no data on whether MAC impacts of MitraClip percutaneous MV edge-to-edge repair. This study sought to investigate the presence procedural success and durability transcatheter MR using MitraClip.One hundred seventy-three patients undergoing significant were studied. Patients with moderate-or-severe (n=28) compared those no-or-mild MAC....
Abstract Aims Interatrial shunts are under evaluation as a treatment for heart failure (HF); however, their in vivo flow performance has not been quantitatively studied. We aimed to investigate the fluid dynamics properties of 0.51 cm orifice diameter Ventura shunt and assess its lumen integrity with serial transesophageal echocardiography (TEE). Methods results Computational (CFD) bench tests were used establish flow‐pressure relationship shunt. Open‐label patients from RELIEVE‐HF trial...
Abstract Repair of mitral regurgitation (MR) with the MitraClip device (Abbot Vascular, Menlo Park, CA) to treat degenerative MR is associated improved acute and long‐term outcomes. There an increasing adoption operators are now testing limits therapy even for unfavorable anatomies. Isolated cleft leaflets rare but represent a challenge percutaneous repair. We present two cases successful repair severe leaflets. In first case, 52‐year‐old male dilated cardiomyopathy ejection fraction (EF)...
Abstract Aims The conceptual framework of proportionate vs. disproportionate mitral regurgitation (MR) translates poorly to individual patients with heart failure (HF) and secondary MR. A novel index, the ratio MR severity left atrial volume (LAV), may identify ‘disproportionate’ a higher risk events. objectives, therefore, were investigate prognostic impact LAV on outcomes among HF severe randomized transcatheter edge-to-edge repair (TEER) MitraClip™ device plus guideline-directed medical...
Evidence-based recommendations for clinical practice are intended to help health care providers and patients make decisions, minimize inappropriate variation, promote effective resource use, improve outcomes, direct future research. SCAI has been engaged in the creation dissemination of guidance documents since 1990s. These a cornerstone Society's education, advocacy, quality improvement initiatives. The Publications Committee is charged with oversight SCAI's program published first...
Introduction: Mitral annular calcification (MAC) has been associated with age, hemodialysis (HD) status, coronary disease, and mortality. While MAC is seen frequently in pts undergoing percutaneous edge-to-edge repair of mitral regurgitation (MR) its impact on survival unknown. Hypothesis: not mortality after MR repair. Methods: Pts who underwent MitraClip between Apr 2009 May 2014 were included. Kaplan-Meier was plotted no MAC. A multivariate Cox regression all-cause performed...